Skip to Main Content

Paper Details

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
9
2021
Author NameAffiliation
Lance C PagliaroThe University of Texas MD Anderson Cancer Center
Eleni EfstathiouThe University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2